Otezla

Product NDC: 55513-519
11-digit product format: 555130519
Labeler code: 55513
Product ID: 55513-519_8d1d49ca-6dc1-4580-b2d5-f69ccb4f1c8e
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: apremilast
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Amgen, Inc
Application: NDA210745
Marketing category: NDA
Marketing start: 2025-08-29
Substance: APREMILAST
Active strength: 75 mg/1
Pharmacologic classes: Phosphodiesterase 4 Inhibitor [EPC], Phosphodiesterase 4 Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N210745-001	OTEZLA XR	APREMILAST	75MG	TABLET, EXTENDED RELEASE / ORAL		RLD, RS	2025-08-29

Orange Book patents#

Current patent rows page 1 of 1 · 9 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N210745-001	7427638	2028-02-16		Drug substance, Drug product	2025-09-24
N210745-001	10092541	2034-05-29	U-2659		2025-09-24
N210745-001	11752129	2042-05-27	U-4264	Drug product	2025-09-24
N210745-001	11752129	2042-05-27	U-4265	Drug product	2025-09-24
N210745-001	11752129	2042-05-27	U-4266	Drug product	2025-09-24
N210745-001	11969409	2042-05-27		Drug product	2025-09-24
N210745-001	12427136	2042-05-27	U-1858		2025-10-28
N210745-001	12427136	2042-05-27	U-4290		2025-10-28
N210745-001	12427136	2042-05-27	U-4291		2025-10-28

Orange Book exclusivity#

Current exclusivity rows page 1 of 1 · 4 matching rows.

Application-product, Exclusivity code, Expiration table
Application-product	Exclusivity code	Expiration
N210745-001	ODE*	2026-07-19
N210745-001	M-299	2026-07-20
N210745-001	PED	2027-01-19
N210745-001	PED	2027-01-20

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N210745-001	OTEZLA XR	75MG	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2025-08-29	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N210745-001	OTEZLA XR	75MG	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2025-08-29	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210745-001	OTEZLA XR	75MG	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2025-08-29	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	OTEZLA XR	75MG	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2025-08-29	`31067a03dcf5…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N210745-001	OTEZLA XR	75MG	TABLET, EXTENDED RELEASE / ORAL	RLD, RS	2025-08-29	`a50c72e98297…`

Observed Orange Book patent history#

Patent history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N210745-001	7427638	2028-02-16		Drug substance, Drug product	2025-09-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210745-001	10092541	2034-05-29	U-2659		2025-09-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210745-001	11752129	2042-05-27	U-4264	Drug product	2025-09-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210745-001	11752129	2042-05-27	U-4265	Drug product	2025-09-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210745-001	11752129	2042-05-27	U-4266	Drug product	2025-09-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210745-001	11969409	2042-05-27		Drug product	2025-09-24	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210745-001	12427136	2042-05-27	U-1858		2025-10-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210745-001	12427136	2042-05-27	U-4290		2025-10-28	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210745-001	12427136	2042-05-27	U-4291		2025-10-28	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N210745-001	7427638	2028-02-16		Drug substance, Drug product	2025-09-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210745-001	10092541	2034-05-29	U-2659		2025-09-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210745-001	11752129	2042-05-27	U-4264	Drug product	2025-09-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210745-001	11752129	2042-05-27	U-4265	Drug product	2025-09-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210745-001	11752129	2042-05-27	U-4266	Drug product	2025-09-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210745-001	11969409	2042-05-27		Drug product	2025-09-24	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210745-001	12427136	2042-05-27	U-1858		2025-10-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210745-001	12427136	2042-05-27	U-4290		2025-10-28	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210745-001	12427136	2042-05-27	U-4291		2025-10-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210745-001	7427638	2028-02-16		Drug substance, Drug product	2025-09-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210745-001	10092541	2034-05-29	U-2659		2025-09-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210745-001	11752129	2042-05-27	U-4264	Drug product	2025-09-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210745-001	11752129	2042-05-27	U-4265	Drug product	2025-09-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210745-001	11752129	2042-05-27	U-4266	Drug product	2025-09-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210745-001	11969409	2042-05-27		Drug product	2025-09-24	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210745-001	12427136	2042-05-27	U-1858		2025-10-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210745-001	12427136	2042-05-27	U-4290		2025-10-28	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210745-001	12427136	2042-05-27	U-4291		2025-10-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	7427638	2028-02-16		Drug substance, Drug product	2025-09-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	10092541	2034-05-29	U-2659		2025-09-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	11752129	2042-05-27	U-4264	Drug product	2025-09-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	11752129	2042-05-27	U-4265	Drug product	2025-09-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	11752129	2042-05-27	U-4266	Drug product	2025-09-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	11969409	2042-05-27		Drug product	2025-09-24	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	12427136	2042-05-27	U-1858		2025-10-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	12427136	2042-05-27	U-4290		2025-10-28	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	12427136	2042-05-27	U-4291		2025-10-28	`31067a03dcf5…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N210745-001	7427638	2028-02-16		Drug substance, Drug product	2025-09-24	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N210745-001	10092541	2034-05-29	U-2659		2025-09-24	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N210745-001	11752129	2042-05-27	U-4264	Drug product	2025-09-24	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N210745-001	11752129	2042-05-27	U-4265	Drug product	2025-09-24	`a50c72e98297…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2026-09-14 22:38:34	2026-08	N210745-001	ODE*	2026-07-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210745-001	M-299	2026-07-20	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210745-001	PED	2027-01-19	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N210745-001	PED	2027-01-20	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N210745-001	ODE*	2026-07-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210745-001	M-299	2026-07-20	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210745-001	PED	2027-01-19	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N210745-001	PED	2027-01-20	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N210745-001	ODE*	2026-07-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210745-001	M-299	2026-07-20	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210745-001	PED	2027-01-19	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N210745-001	PED	2027-01-20	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	ODE*	2026-07-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	M-299	2026-07-20	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	PED	2027-01-19	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N210745-001	PED	2027-01-20	`31067a03dcf5…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N210745-001	ODE*	2026-07-19	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N210745-001	M-299	2026-07-20	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N210745-001	PED	2027-01-19	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	N210745-001	PED	2027-01-20	`a50c72e98297…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Otezla
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
APREMILAST	75 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
UP7QBP99PN	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 18 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1492732	Internal RxNorm lookup
1492738	Internal RxNorm lookup
1492740	Internal RxNorm lookup
1492742	Internal RxNorm lookup
1492744	Internal RxNorm lookup
1492746	Internal RxNorm lookup
1492747	Internal RxNorm lookup
1492748	Internal RxNorm lookup
1605454	Internal RxNorm lookup
1605455	Internal RxNorm lookup
2682429	Internal RxNorm lookup
2682430	Internal RxNorm lookup
2682431	Internal RxNorm lookup
2682432	Internal RxNorm lookup
2723448	Internal RxNorm lookup
2723452	Internal RxNorm lookup
2724366	Internal RxNorm lookup
2724367	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
f6b1f516-4972-4d82-bced-113e47b41cc5	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
60f3bca3-f66c-4779-8fd1-16dc6df0a73e	Product name	6	20250818

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
55513-519-30	Otezla	30 in 1 BOTTLE	TABLET, FILM COATED	30		34

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55513-519-30	EA - Each	55513-519	d2e91a96-9f51-445b-b9e8-e86dc070e43e	1	2025-10-14

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Otezla	APREMILAST	Amgen, Inc	f6b1f516-4972-4d82-bced-113e47b41cc5	2026-09-02	Warnings, Adverse reactions	Exact identifier application applno (NDA): 210745 application number: NDA210745 ndc (product): 55513-519

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
UP7QBP99PN	APREMILAST	608141-41-9	APREMILAST

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
2724367	{14 (24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla]) / 4 (apremilast 10 MG Oral Tablet [Otezla]) / 4 (apremilast 20 MG Oral Tablet [Otezla]) / 19 (apremilast 30 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20/30/75 Starter Pack]	BPCK	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682432	{4 (apremilast 10 MG Oral Tablet [Otezla]) / 23 (apremilast 20 MG Oral Tablet [Otezla]) } Pack [Otezla 14-Day 10/20 Starter Pack]	BPCK	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492748	{4 (apremilast 10 MG Oral Tablet [Otezla]) / 4 (apremilast 20 MG Oral Tablet [Otezla]) / 19 (apremilast 30 MG Oral Tablet [Otezla]) } Pack [Otezla 14-Day 10/20/30 Starter Pack]	BPCK	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1605455	{4 (apremilast 10 MG Oral Tablet [Otezla]) / 4 (apremilast 20 MG Oral Tablet [Otezla]) / 47 (apremilast 30 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20/30 Starter Pack]	BPCK	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682430	{4 (apremilast 10 MG Oral Tablet [Otezla]) / 51 (apremilast 20 MG Oral Tablet [Otezla]) } Pack [Otezla 28-Day 10/20 Starter Pack]	BPCK	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2724366	{14 (24 HR apremilast 75 MG Extended Release Oral Tablet) / 4 (apremilast 10 MG Oral Tablet) / 4 (apremilast 20 MG Oral Tablet) / 19 (apremilast 30 MG Oral Tablet) } Pack	GPCK	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682431	{4 (apremilast 10 MG Oral Tablet) / 23 (apremilast 20 MG Oral Tablet) } Pack	GPCK	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492747	{4 (apremilast 10 MG Oral Tablet) / 4 (apremilast 20 MG Oral Tablet) / 19 (apremilast 30 MG Oral Tablet) } Pack	GPCK	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1605454	{4 (apremilast 10 MG Oral Tablet) / 4 (apremilast 20 MG Oral Tablet) / 47 (apremilast 30 MG Oral Tablet) } Pack	GPCK	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682429	{4 (apremilast 10 MG Oral Tablet) / 51 (apremilast 20 MG Oral Tablet) } Pack	GPCK	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492732	apremilast 10 MG Oral Tablet	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492740	apremilast 20 MG Oral Tablet	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492744	apremilast 30 MG Oral Tablet	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2723448	apremilast 75 MG 24HR Extended Release Oral Tablet	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682431	apremilast starter pack 10 MG (4), 20 MG (23) Oral Tablet 14-Day Pack	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492747	apremilast starter pack 10 MG (4), 20 MG (4), 30 MG (19) Oral Tablet 14-Day Pack	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2724366	apremilast starter pack 10 MG (4), 20 MG (4), 30 MG (19), 75 MG XR (14) Oral Tablet 28-Day Pack	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1605454	apremilast starter pack 10 MG (4), 20 MG (4), 30 MG (47) Oral Tablet 28-Day Pack	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682429	apremilast starter pack 10 MG (4), 20 MG (51) Oral Tablet 28-Day Pack	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492738	Otezla 10 MG Oral Tablet	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682432	Otezla 14-Day 10/20 Starter Pack	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492748	Otezla 14-Day 10/20/30 Starter Pack	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492742	Otezla 20 MG Oral Tablet	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682430	Otezla 28-Day 10/20 Starter Pack	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1605455	Otezla 28-Day 10/20/30 Starter Pack	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2724367	Otezla 28-Day 10/20/30/75 Starter Pack	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492746	Otezla 30 MG Oral Tablet	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2723452	Otezla XR 75 MG 24HR Extended Release Oral Tablet	PSN	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2723452	24 HR apremilast 75 MG Extended Release Oral Tablet [Otezla]	SBD	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492738	apremilast 10 MG Oral Tablet [Otezla]	SBD	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492742	apremilast 20 MG Oral Tablet [Otezla]	SBD	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492746	apremilast 30 MG Oral Tablet [Otezla]	SBD	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2723448	24 HR apremilast 75 MG Extended Release Oral Tablet	SCD	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492732	apremilast 10 MG Oral Tablet	SCD	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492740	apremilast 20 MG Oral Tablet	SCD	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492744	apremilast 30 MG Oral Tablet	SCD	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682431	apremilast 14-day 10/20 starter pack	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492747	apremilast 14-day 10/20/30 starter pack	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682429	apremilast 28-day 10/20 starter pack	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1605454	apremilast 28-day 10/20/30 starter pack	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2723448	apremilast 75 MG 24HR Extended Release Oral Tablet	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2724366	apremilast starter pack 10 MG (4), 20 MG (4), 30 MG (19), 75 MG XR (14) Oral Tablet 28-Day Pack	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492738	Otezla 10 MG Oral Tablet	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682432	Otezla 14-Day 10/20 Starter Pack	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492748	Otezla 14-Day 10/20/30 Starter Pack	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492742	Otezla 20 MG Oral Tablet	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2682430	Otezla 28-Day 10/20 Starter Pack	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1605455	Otezla 28-Day 10/20/30 Starter Pack	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2724367	Otezla 28-Day 10/20/30/75 Starter Pack	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
1492746	Otezla 30 MG Oral Tablet	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34
2723452	Otezla XR 75 MG 24HR Extended Release Oral Tablet	SY	f6b1f516-4972-4d82-bced-113e47b41cc5	34

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Sample	Exclude flag	Status
55513-519-30	55513051930	30 TABLET, FILM COATED in 1 BOTTLE (55513-519-30)	2025-08-31	No	No	Current